Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.
Molecular mechanism underlying a Cx50-linked congenital cataract.
Surgical Procedures, Operative
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor. J Thorac Oncol. 2011 Nov; 6(11 Suppl 4):S1810-1.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Clinical Trials as Topic
Hepatocyte Growth Factor
Humans
Lung Neoplasms
Proto-Oncogene Proteins c-met
authors with profiles
Ravi Salgia